Clinical Trials Browser

Completed × Disease Progression × Genitourinary × Clear all

NCT02533258 2025-07-16

Post-Marketing Surveillance Study To Observe INLYTA® Treatment Dosing Pattern, Safety And Effectiveness In Taiwan Real World Routine Practice

13 enrolled 14 charts

Carcinoma, Renal Cell, Disease Progression

NCT03154190 2025-01-24

Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer

Phase NA Completed

128 enrolled 24 charts

BreastDermatologicGastrointestinalGenitourinaryGynecologicMyeloidOther hematologic neoplasmSarcomaThoracic

Urinary Bladder Neoplasms, Bone Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Esophageal Neoplasms, Melanoma, Myelodysplastic Syndromes, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Recurrence, Sarcoma, Stomach Neoplasms, Leukemia, Myeloid, Acute, Disease Progression, Triple Negative Breast Neoplasms

NCT06235853 2024-02-01

Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Recurrence, Disease Progression

NCT04723121 2021-01-25

Can We Predict of the Response of High Risk Non Muscle Invasive Bladder Cancer Patients to Intravesical Bacillus Calmette-Guerin? The Role of Immunological Markers

Phase NA Completed

Urinary Bladder Neoplasms, Recurrence, Disease Progression

NCT03715660 2019-11-21

Xpert Bladder Cancer Monitor; Prospective, Single, Tertiary-care Center Implementation Study

Phase NA Completed

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Recurrence, Disease Progression

NCT03174912 2017-06-05

In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both?

Phase 4 Completed

Urinary Bladder Neoplasms, Recurrence, Disease Progression

NCT01886677 2017-03-03

Improving Energy Balance in Men With Prostate Cancer

Phase NA Completed

Motor Activity, Prostatic Neoplasms, Weight Loss, Disease Progression

NCT01692262 2014-06-19

PYRUS

Phase 1 Completed

Prostatic Neoplasms, Disease Progression